RCS - Abingdon Health PLC - CS (Lifesciences) Ltd contract win

Abingdon HealthAnnouncement

08/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250108:nRSH4691Sa&default-theme=true

RNS Number : 4691S  Abingdon Health PLC  08 January 2025

 

Abingdon Health plc

("Abingdon Health", the "Group" or the "Company")

 

CS (Lifesciences) Ltd contract win

Abingdon subsidiary wins >£500k contract

 

York, U.K. 8 January 2025: Abingdon Health plc (AIM: ABDX), a leading
international lateral flow contract research (CRO) and contract development
and manufacturing organisation (CDMO), announces that its subsidiary company,
CS (Lifesciences) Ltd, has won a contract with a major global diagnostics
company for work relating to quality management systems and regulatory
approvals. The contract will commence in March 2025 and continue for 12
months, providing revenue of >£500k spread across that period.

 

Abingdon Health acquired CS (Lifesciences) Ltd, a consultancy specialising in
meeting compliance requirements in international IVD and medical device
markets, in August 2024, broadening Abingdon's service offering and enabling
the Group to fully support its customers in bringing their products from idea
through to commercial success.

 

For more information on CS (Lifesciences) Ltd, see its brochure here
(https://cslifesciences.com/wp-content/uploads/2024/12/CS-Brochure-Website-Nov-2024.pdf)
.

 

Edwin Lindsay, Managing Director of CS (Lifesciences) Ltd said, "I am
delighted that we can announce this contract win with a major entity in the
medical diagnostics sector. It illustrates that our focussed skilled personnel
are able to offer specialised expertise in quality and regulatory approval
which is competitive and appealing to even the major players in the in vitro
diagnostics sector."

 

Chris Yates, CEO of Abingdon said, "This contact win illustrates one aspect of
Abingdon's service offering in the medical diagnostic sector and to the wider
med-tech industry. Our full CDMO service, offering services to an
international customer base, has been enhanced by our recent acquisition of CS
(Lifesciences) Ltd, and I congratulate Edwin and the team on this contract win
with a major diagnostics company."

 

Enquiries:

 

 Abingdon Health plc                           www.abingdonhealth.com/investors/ (http://www.abingdonhealth.com/investors/)
 Chris Yates, Chief Executive Officer                                                   Via Walbrook PR
 Chris Hand, Executive Chairman

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com
                                               (mailto:abingdon@walbrookpr.com)
 Paul McManus / Alice Woodings                 Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654
 Phillip Marriage                              +44 (0)7867 984 082

 

About Abingdon Health plc

Abingdon Health Group is a leading IVD and med-tech contract service
provider offering its comprehensive services to an international customer
base.

 

The Company's CDMO division
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.abingdonhealth.com_services_&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=HA76POaNPDBWSuSNqpvm6h6sTVAmwDfGPxyLLvvNBHg&e=)
 offers lateral flow product development, technology transfer, manufacturing
and regulatory support services to customers looking to develop new assays or
transfer existing laboratory-based assays to a lateral flow format. Abingdon
Health's CDMO division has the internal capabilities to take lateral flow
projects, in areas such as infectious disease and clinical testing, including
companion diagnostics, animal health and environmental testing, from initial
concept through to routine and large-scale manufacturing: from "idea to
commercial success".

 

Abingdon's regulatory services companies, Compliance Solutions (Life
Sciences)
(https://urldefense.proofpoint.com/v2/url?u=https-3A__cslifesciences.com&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=PvbE1xuJgNrAaK0I9QSrYjO3acai4ITHsbheoH-Cavc&e=)
 and IVDeology
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.ivdeology.co.uk&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=mbRruUP_NEre93fFYpNkBweGVcmSCnXpjUyMQmUx1yI&e=)
, provide a broad range of regulatory services to the in vitro diagnostic and
wider medical device industry, to support customers in bringing products to
market across a range of territories including the USA, EU and the UK. Our
consultancy services range from design, implementation and maintenance of
quality management systems, preparation of technical files for regulatory
approvals, part-time and interim management support, auditing both internal
and external suppliers, management reviews and presentations, training and
mentoring.

 

Abingdon Health's Abingdon Simply Test range of self-tests is an e-commerce
platform that offers a range of self-tests to empowers consumers to manage
their own health and wellbeing. The Abingdon Simply Test
(https://urldefense.proofpoint.com/v2/url?u=http-3A__www.abingdonsimplytest.com&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=71SLyhJsm1hJqJvXuK0jPc4-fr_IZIW_VOOfo4sJwQw&e=)
 e-commerce site offers consumers a range of information to support them in
making informed decisions on the tests available. In addition, the site
provides Abingdon's contract services customers with a potential route to
market for self-tests. The Abingdon Simply Test range is also sold through
international distributors and through other channels in
the UK and Ireland, such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England.

 

For more information visit: www.abingdonhealth.com
(https://urldefense.proofpoint.com/v2/url?u=http-3A__www.abingdonhealth.com_&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=Cd1Yy0EoU5vx33xedoTE3bCKbljgDOIRD8ol-bb59BM&e=)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASSIFWWEISESF